Marijuana: a time-honored but untested treatment for epilepsy

Area of Science:

• Neuroscience
• Pharmacology
• Cannabinoid Science

Background:

• The endocannabinoid system in the brain suggests a potential therapeutic role for cannabis in managing seizures.
• Current evidence supporting cannabis for epilepsy treatment is largely anecdotal, lacking robust randomized controlled trials.

Purpose of the Study:

• To review the current understanding of the endocannabinoid system's role in seizure disorders.
• To evaluate the existing evidence, safety profile, and administration methods for cannabis as an epilepsy treatment from a Canadian viewpoint.

Main Methods:

• This study is a review of existing literature and research on cannabis and epilepsy.
• The review adopts a Canadian perspective, considering the local context and regulatory environment.

Main Results:

• The endocannabinoid system provides a theoretical basis for cannabis's anticonvulsant effects.
• Anecdotal reports suggest potential benefits, but rigorous clinical trials are absent.
• Optimal dosage and administration routes for cannabis in epilepsy remain undetermined.
• Cannabis appears safer than many conventional antiepileptic drugs and other controlled substances like tobacco and alcohol.

Conclusions:

• While the endocannabinoid system offers a promising avenue for epilepsy treatment with cannabis, further high-quality research, including randomized controlled trials, is essential.
• Establishing appropriate dosages and delivery methods is critical for clinical application.
• Cannabis presents a relatively favorable safety profile compared to certain pharmaceuticals and substances of abuse.